![](/img/cover-not-exists.png)
MA09.09 First-In-Human Phase 1 Study of ABBV-399, an Antibody-Drug Conjugate (ADC) Targeting C-Met, in Patients with Non-Small Cell Lung Cancer (NSCLC)
Angevin, Eric, Strickler, John, Weekes, Colin, Heist, Rebecca, Morgensztern, Daniel, Fan, Xiaolin, Olyaie, Ozzie, Motwani, Monica, Afar, Daniel, Naumovski, Louie, Kelly, KarenVolume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2016.11.449
Date:
January, 2017
File:
PDF, 178 KB
english, 2017